The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea (BOC)

Konkuk University Medical Center

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease; COPD

Treatments: Other: Indirect cost; Other: Direct cost

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02750189

KUH1010636

Details and patient eligibility

About

The purpose of this study is to estimate a direct/indirect medical cost and to provide evidence establishing efficient strategies to reduce medical costs of COPD in Korea.

Full description

This study is a multi-center research on economic burdens of COPD for a year. It is composed of three phases detailed as follow.

Phase 1: Direct Cost Estimation in COPD patients (N = 400) Direct cost determined as amount of money expended to medical institutes for treatment. Estimated costs, based on the information from Health insurance review agency(HIRA) and The National Health and Nutrition Examination Survey (NHANES) data, are collected.

Phase 2: Indirect cost Estimation by Sampling Survey in COPD patient Indirect cost is extra-expanses excluding hospital fees, including cost for transportation, medical instruments, home care services and loss of labor capacity reduction. The information was collected by structured questionnaire for 12 weeks.

Phase 3: Direct/Indirect cost is validated and analyzed based on the collected information from phase 1 and 2 according to severity defined by the GOLD guideline.

Enrollment: 390 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Over 20 years old
• COPD patients

Exclusion criteria

• Patients who disagree with participating in research

Trial design

390 participants in 4 patient groups

Mild Group

Description:

FEV₁/FVC \<70% and FEV₁≥80% direct/indirect cost

Treatment:

Other: Indirect cost

Other: Direct cost

Moderate Group

Description:

FEV₁/FVC \<70% and 50%≤FEV₁≤80% direct/indirect cost

Treatment:

Other: Indirect cost

Other: Direct cost

Severe Group

Description:

FEV₁/FVC \<70% and 30%≤FEV₁≤50% direct/indirect cost

Treatment:

Other: Indirect cost

Other: Direct cost

Very Severe Group

Description:

FEV₁/FVC \<70% and FEV₁\<30% direct/indirect cost

Treatment:

Other: Indirect cost

Other: Direct cost